Rafael Holdings Inc Revenue Growth Rates (RFL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rafael Holdings Inc  (NYSE: RFL)
 

RFL's Revenue Growth by Quarter and Year

Rafael Holdings Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RFL/growth
https://api.csimarket.com/api/v1/companies/RFL/fundamentals
https://api.csimarket.com/api/v1/companies/RFL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
RFL Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter July 0.00
3rd Quarter April 0.18
2nd Quarter January 0.24
1st Quarter October 0.35
FY 0.77

RFLs Annual Revenue
Rafael Holdings Inc's Revenue in the fiscal year 2026 $ 0.21 millions
Rafael Holdings Inc's Revenue in the fiscal year 2025 $ 0.92 millions
Rafael Holdings Inc's Revenue in the fiscal year 2024 $ 0.64 millions
Rafael Holdings Inc's Revenue in the fiscal year 2023 $ 0.28 millions
Rafael Holdings Inc's Revenue in the fiscal year 2022 $ 0.41 millions




RFL Revenue fourth quarter 2025 Y/Y Growth Comment
Rafael Holdings Inc in the fourth quarter 2025 recorded of $ 0.00 millions.

Looking into fourth quarter 2025 results within Major Pharmaceutical Preparations industry 35 other companies have achieved higher Revenue growth. While Rafael Holdings Inc' s Revenue meltdown of -100% ranks overall at the positon no. 210 in the fourth quarter 2025.


RFL Revenue ( Y/Y Growth %) 2025
 FY 2024 FY 2023 FY 2022
4th Quarter July -
3rd Quarter April 125 %
2nd Quarter January 84.62 %
1st Quarter October 105.88 %
FY   4.05 %

Financial Statements
Rafael Holdings Inc's fourth quarter 2025 Revenue $ 0.00 millions RFL's Income Statement
Rafael Holdings Inc's fourth quarter 2024 Revenue $ 0.36 millions Quarterly RFL's Income Statement


RFL Revenue (Quarter on Quarter Growth %)

 2025
 FY 2024 FY 2023 FY 2022
4th Quarter July -
3rd Quarter April -25 %
2nd Quarter January -31.43 %
1st Quarter October -2.78 %
FY (Year on Year)   4.05 %


Back to RFL Growth rate Comparisons >> Back to RFL Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #36
Healthcare Sector #61
Overall #210

Revenue Y/Y Growth Statistics
High Average Low
373.24 % 12.31 % -92.88 %
(Jul 31 2025)   (Oct 31 2022)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #36
Healthcare Sector #61
Overall #210
Revenue Y/Y Growth Statistics
High Average Low
373.24 % 12.31 % -92.88 %
(Jul 31 2025)   (Oct 31 2022)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Rafael Holdings Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
394.12 % 12.88 % -92.11 %
(Apr 30 2024)  


RFL's IV. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Rafael Holdings Inc come out even worse considering the 0.18 millions a quarter before.

Within Major Pharmaceutical Preparations industry 161 other companies have achieved higher Revenue quarter on quarter growth. While Rafael Holdings Inc's Revenue growth quarter on quarter, overall rank is 3340.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #162
Healthcare Sector #467
Overall #3340
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #162
Healthcare Sector #467
Overall #3340
Revenue Q/Q Growth Statistics
High Average Low
394.12 % 12.88 % -92.11 %
(Apr 30 2024)  


RFL's IV. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Rafael Holdings Inc come out even worse considering the 0.18 millions a quarter before.

Within Major Pharmaceutical Preparations industry 161 other companies have achieved higher Revenue quarter on quarter growth. While Rafael Holdings Inc's Revenue growth quarter on quarter, overall rank is 3340.


Rafael Holdings Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jul 31 2026)		 12 Months Ending (Apr 30 2026) 12 Months Ending (Oct 31 2025) 12 Months Ending (Oct 31 2025) 12 Months Ending (Jul 31 2025)
Cumulative Revenue 12 Months Ending $ 0.00
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking # 480
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking # 2230


Cumulative Revenue growth Comment
Rafael Holdings Inc realized trailing twelve months of $ 0 millions, in the Jul 31 2026, compare to Revenue of $ 1 millions a year ago.

In the Healthcare sector 113 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 480.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 105
Healthcare Sector # 114
Overall # 480

Revenue TTM Y/Y Growth Statistics
High Average Low
156.73 %
 5.02 %
-90.7 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 105
Sector # 326
S&P 500 # 2230
Cumulative Revenue growth Comment
Rafael Holdings Inc realized trailing twelve months of $ 0 millions, in the Jul 31 2026, compare to Revenue of $ 1 millions a year ago.

In the Healthcare sector 113 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 480.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 105
Healthcare Sector # 114
Overall # 480

Revenue TTM Y/Y Growth Statistics
High Average Low
156.73 %
5.02 %
-90.7 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 105
Sector # 326
S&P 500 # 2230




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RFL's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Jul 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jul 31 2026
Lakeland Industries Inc -4.49%$ -4.490 millions
Kewaunee Scientific Corporation-6.50%$ -6.499 millions
Nutriband Inc -29.71%$ -29.711 millions


About Rafael Holdings Inc Revenue Growth Rates (RFL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Rafael Holdings Inc (CIK 1713863).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-113659
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Rafael Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.